首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1633877

全球孤兒藥 CDMO 市場分析與預測（至 2033 年）：類型、產品、服務、技術、應用、最終用戶、階段、流程、形式和組件

Orphan Drugs CDMO Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Application, End User, Stage, Process, Mode, Component

出版日期: 2025年01月13日 | 出版商:

Global Insight Services | 英文 363 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球孤兒藥 CDMO 市場預計將從 2023 年的 135 億美元成長到 2033 年的 278 億美元，複合年增長率為 7.4%。

孤兒藥 CDMO 市場包括專門針對孤兒藥（用於治療罕見疾病的藥物）的合約開發和製造服務。該市場包括解決罕見疾病藥物開發的獨特課題和監管要求的解決方案，包括配方、擴大規模、臨床試驗生產和商業化支援。

受罕見疾病發病率上升和有利的監管框架的推動，罕見疾病 CDMO 正在強勁擴張。生物製劑製造是表現最佳的子領域，這受到對先進療法和個人化醫療日益增長的需求的推動。在技術進步和具有成本效益的製造解決方案的支持下，小分子藥物製造表現排名第二。從地區來看，北美憑藉著完善的醫療基礎設施、強大的研發能力以及政府的支持政策引領市場。歐洲是第二大最受青睞的地區，這得益於戰略夥伴關係、創新激勵以及對罕見疾病治療日益增長的興趣。亞太地區面積較小，但由於醫療保健條件改善、投資增加和製藥業蓬勃發展，其發展勢頭強勁。這一充滿活力的市場格局凸顯了 CDMO 在解決未滿足的醫療需求和推動罕見疾病藥物開發創新方面發揮的關鍵作用。

2023年孤兒藥CDMO市場預計將達到1.5億單位，到2033年將達到2.5億單位。生物製劑的市佔率最高，為 45%，其次是小分子藥物，為 30%，基因療法為 25%。這一增長是由個人化醫療需求的不斷增長和罕見疾病發病率的上升所推動的。市場的主要參與者包括 Lonza Group、Catalent 和 Thermo Fisher Scientific，每家都佔有強大的市場佔有率。Lonza Group 以其對先進生物製造技術的投資而聞名，而 Catalent 則專注於擴大其基因治療能力。

競爭格局由策略聯盟和合併塑造，而《孤兒藥法案》和《市場條件條例》等監管框架則影響市場動態。這些法規透過提供市場獨佔權和稅收抵免等激勵措施對於促進創新至關重要。預計到 2033 年，受技術進步和監管環境改善的推動，研發投資將增加 15%。市場前景依然樂觀，生物製劑和基因治療領域存在巨大商機。然而，課題依然存在，包括高昂的開發成本和監管障礙。人工智慧和機器學習在藥物開發過程中的融合有望開闢新的成長前景。

由於先進的醫療基礎設施和對藥物研究的大量投資，北美孤兒藥 CDMO 市場正在蓬勃發展。美國在該地區處於領先地位，受益於強有力的監管框架和對罕見疾病的大量資金。這促進了創新並加速了藥物開發過程。接下來是加拿大，該國政府的政策支持生技產業的蓬勃發展。

歐洲市場的特點是協作的監管環境和大量孤兒藥開發資金。歐洲藥品管理局在促進市場准入方面發揮著至關重要的作用。德國和法國等國家因其強大的製藥業和對罕見疾病研究的重視而脫穎而出。

由於醫療保健支出的增加和對罕見疾病的認識的提高，亞太地區的孤兒藥 CDMO 市場正在快速成長。中國和日本是領先的國家，由政府主導支持研發。該地區的生物技術產業正在擴大，進一步增強了其市場潛力。

以巴西和墨西哥為首的拉丁美洲呈現出良好的成長動能。這些國家正在投資本國醫療保健基礎設施，並與全球製藥公司建立合作關係。這提高了我們開發和生產罕見疾病藥物的能力。

中東和非洲正逐漸成為罕見疾病CDMO市場的參與者。沙烏地阿拉伯和南非等國家正在投資醫療進步。在不斷增長的需求和政府舉措的推動下，這些國家正在建立支持罕見疾病治療發展的能力。

概述
北美
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 瑞典
- 瑞士
- 丹麥
- 芬蘭
- 俄羅斯
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 新加坡
- 印尼
- 台灣
- 馬來西亞
- 其他亞太地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
中東/非洲
- 沙烏地阿拉伯
- 阿拉伯聯合酋長國
- 南非
- 其他中東/非洲

第18章競爭格局

概述
市場佔有率分析
大公司定位
競爭領導映射
供應商基準測試
對標發展策略

第19章公司簡介

Lonza
Catalent
Samsung Biologics
WuXi Biologics
Boehringer Ingelheim BioXcellence
Fujifilm Diosynth Biotechnologies
AGC Biologics
Thermo Fisher Scientific
Recipharm
Piramal Pharma Solutions
Almac Group
Biocon
CordenPharma
Patheon
Ajinomoto Bio-Pharma Services
Abzena
Rentschler Biopharma
KBI Biopharma
Cambrex
Siegfried

簡介目錄

Product Code: GIS26276

The orphan drugs CDMO market is anticipated to expand from $13.5 billion in 2023 to $27.8 billion by 2033, reflecting a CAGR of 7.4%.

The Orphan Drugs CDMO market encompasses the specialized contract development and manufacturing services dedicated to orphan drugs, which are pharmaceutical agents developed to treat rare diseases. This market involves tailored solutions in drug formulation, scale-up, clinical trial production, and commercialization support, addressing the unique challenges and regulatory requirements of orphan drug development, thereby facilitating the availability of treatments for underserved patient populations.

The Orphan Drugs CDMO Market is witnessing robust expansion, driven by the rising prevalence of rare diseases and favorable regulatory frameworks. Biologics manufacturing emerges as the top-performing sub-segment, attributed to the increasing demand for advanced therapeutics and personalized medicine. Small molecule production follows as the second-highest performing sub-segment, supported by technological advancements and cost-effective manufacturing solutions. Regionally, North America leads the market, benefiting from well-established healthcare infrastructure, strong R&D capabilities, and supportive government policies. Europe stands as the second most lucrative region, propelled by strategic collaborations, innovation incentives, and a growing focus on rare disease treatment. The Asia-Pacific region, though smaller, is gaining momentum, driven by improving healthcare access, increasing investments, and a burgeoning pharmaceutical industry. This dynamic market landscape underscores the critical role of CDMOs in addressing unmet medical needs and fostering innovation in orphan drug development.

In 2023, the Orphan Drugs CDMO Market recorded a volume of 150 million units, with expectations to reach 250 million units by 2033. The biologics segment commands the largest market share at 45%, followed by small molecules at 30%, and gene therapies at 25%. This growth is driven by increasing demand for personalized medicine and the rising prevalence of rare diseases. Key players in the market include Lonza Group, Catalent, and Thermo Fisher Scientific, each maintaining a robust presence. Lonza Group is particularly noted for its investment in advanced biomanufacturing technologies, while Catalent focuses on expanding its gene therapy capabilities.

The competitive landscape is shaped by strategic collaborations and mergers, with regulatory frameworks such as the Orphan Drug Act and EMA Orphan Regulation influencing market dynamics. These regulations offer incentives, including market exclusivity and tax credits, which are crucial for driving innovation. The market outlook remains optimistic, with significant opportunities in biologics and gene therapies. However, challenges such as high development costs and regulatory hurdles persist. The integration of AI and machine learning in drug development processes is anticipated to unlock new growth prospects.

The North American orphan drugs CDMO market is robust, driven by advanced healthcare infrastructure and significant investments in pharmaceutical research. The United States leads this region, benefiting from a strong regulatory framework and substantial funding for rare diseases. This fosters innovation and accelerates drug development processes. Canada follows, with supportive government policies and growing biotech industry presence.

Europe's market is characterized by a collaborative regulatory environment and substantial funding for orphan drug development. The European Medicines Agency plays a pivotal role in facilitating market access. Countries like Germany and France are prominent due to their strong pharmaceutical sectors and emphasis on rare disease research.

Asia Pacific is experiencing rapid growth in the orphan drugs CDMO market, driven by increasing healthcare expenditure and rising awareness of rare diseases. China and Japan are key players, with government initiatives supporting research and development. The region's expanding biotechnology sector further enhances its market potential.

Latin America shows promising growth, with Brazil and Mexico leading the charge. These countries are investing in healthcare infrastructure and fostering partnerships with global pharmaceutical companies. This enhances their capacity to develop and manufacture orphan drugs.

The Middle East and Africa region is gradually emerging in the orphan drugs CDMO market. Countries like Saudi Arabia and South Africa are investing in healthcare advancements. They are building capabilities to support the development of treatments for rare diseases, driven by increasing demand and government initiatives.

Key Companies

Lonza, Catalent, Samsung Biologics, Wu Xi Biologics, Boehringer Ingelheim Bio Xcellence, Fujifilm Diosynth Biotechnologies, AGC Biologics, Thermo Fisher Scientific, Recipharm, Piramal Pharma Solutions, Almac Group, Biocon, Corden Pharma, Patheon, Ajinomoto Bio- Pharma Services, Abzena, Rentschler Biopharma, KBI Biopharma, Cambrex, Siegfried

Sources

U.S. Food and Drug Administration - Orphan Products Clinical Trials Grants Program, European Medicines Agency - Orphan Medicines, National Institutes of Health - Office of Rare Diseases Research, World Health Organization - Rare Diseases, International Rare Diseases Research Consortium, Orphanet - Portal for Rare Diseases and Orphan Drugs, National Organization for Rare Disorders, Genetic and Rare Diseases Information Center, European Organisation for Rare Diseases (EURORDIS), Global Genes, International Conference on Rare Diseases & Orphan Drugs, World Orphan Drug Congress, Rare Disease Day (EURORDIS Event), U.S. National Library of Medicine - PubMed, National Center for Advancing Translational Sciences, European Commission - Health and Food Safety, Biotechnology Innovation Organization, U.S. Department of Health & Human Services - Health Resources and Services Administration, International Society for Pharmaceutical Engineering, American Society of Gene & Cell Therapy

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

1: Orphan Drugs CDMO Market Overview

1.1 Objectives of the Study
1.2 Orphan Drugs CDMO Market Definition and Scope of the Report
1.3 Report Limitations
1.4 Years & Currency Considered in the Study
1.5 Research Methodologies
- 1.5.1 Secondary Research
- 1.5.2 Primary Research
- 1.5.3 Market Size Estimation: Top-Down Approach
- 1.5.4 Market Size Estimation: Bottom-Up Approach
- 1.5.5 Data Triangulation and Validation

2: Executive Summary

2.1 Summary
2.2 Key Opinion Leaders
2.3 Key Highlights of the Market, by Type
2.4 Key Highlights of the Market, by Product
2.5 Key Highlights of the Market, by Services
2.6 Key Highlights of the Market, by Technology
2.7 Key Highlights of the Market, by Application
2.8 Key Highlights of the Market, by End User
2.9 Key Highlights of the Market, by Stage
2.10 Key Highlights of the Market, by Process
2.11 Key Highlights of the Market, by Mode
2.12 Key Highlights of the Market, by Component
2.13 Key Highlights of the Market, by North America
2.14 Key Highlights of the Market, by Europe
2.15 Key Highlights of the Market, by Asia-Pacific
2.16 Key Highlights of the Market, by Latin America
2.17 Key Highlights of the Market, by Middle East
2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

3.1 Market Attractiveness Analysis, by Region
3.2 Market Attractiveness Analysis, by Type
3.3 Market Attractiveness Analysis, by Product
3.4 Market Attractiveness Analysis, by Services
3.5 Market Attractiveness Analysis, by Technology
3.6 Market Attractiveness Analysis, by Application
3.7 Market Attractiveness Analysis, by End User
3.8 Market Attractiveness Analysis, by Stage
3.9 Market Attractiveness Analysis, by Process
3.10 Market Attractiveness Analysis, by Mode
3.11 Market Attractiveness Analysis, by Component
3.12 Market Attractiveness Analysis, by North America
3.13 Market Attractiveness Analysis, by Europe
3.14 Market Attractiveness Analysis, by Asia-Pacific
3.15 Market Attractiveness Analysis, by Latin America
3.16 Market Attractiveness Analysis, by Middle East
3.17 Market Attractiveness Analysis, by Africa

4: Orphan Drugs CDMO Market Outlook

4.1 Orphan Drugs CDMO Market Segmentation
4.2 Market Dynamics
- 4.2.1 Market Drivers
- 4.2.2 Market Trends
- 4.2.3 Market Restraints
- 4.2.4 Market Opportunities
4.3 Porters Five Forces Analysis
- 4.3.1 Threat of New Entrants
- 4.3.2 Threat of Substitutes
- 4.3.3 Bargaining Power of Buyers
- 4.3.4 Bargaining Power of Supplier
- 4.3.5 Competitive Rivalry
4.4 PESTLE Analysis
4.5 Value Chain Analysis
4.6 4Ps Model
4.7 ANSOFF Matrix

5: Orphan Drugs CDMO Market Strategy

5.1 Parent Market Analysis
5.2 Supply-Demand Analysis
5.3 Consumer Buying Interest
5.4 Case Study Analysis
5.5 Pricing Analysis
5.6 Regulatory Landscape
5.7 Supply Chain Analysis
5.8 Competition Product Analysis
5.9 Recent Developments

6: Orphan Drugs CDMO Market Size

6.1 Orphan Drugs CDMO Market Size, by Value
6.2 Orphan Drugs CDMO Market Size, by Volume

7: Orphan Drugs CDMO Market, by Type

7.1 Market Overview
7.2 Small Molecule
- 7.2.1 Key Market Trends & Opportunity Analysis
- 7.2.2 Market Size and Forecast, by Region
7.3 Biologics
- 7.3.1 Key Market Trends & Opportunity Analysis
- 7.3.2 Market Size and Forecast, by Region
7.4 Gene Therapy
- 7.4.1 Key Market Trends & Opportunity Analysis
- 7.4.2 Market Size and Forecast, by Region
7.5 Cell Therapy
- 7.5.1 Key Market Trends & Opportunity Analysis
- 7.5.2 Market Size and Forecast, by Region
7.6 Antibody
- 7.6.1 Key Market Trends & Opportunity Analysis
- 7.6.2 Market Size and Forecast, by Region
7.7 Peptide
- 7.7.1 Key Market Trends & Opportunity Analysis
- 7.7.2 Market Size and Forecast, by Region
7.8 RNA-based
- 7.8.1 Key Market Trends & Opportunity Analysis
- 7.8.2 Market Size and Forecast, by Region
7.9 Viral Vectors
- 7.9.1 Key Market Trends & Opportunity Analysis
- 7.9.2 Market Size and Forecast, by Region
7.10 Non-Viral Vectors
- 7.10.1 Key Market Trends & Opportunity Analysis
- 7.10.2 Market Size and Forecast, by Region
7.11 Others
- 7.11.1 Key Market Trends & Opportunity Analysis
- 7.11.2 Market Size and Forecast, by Region

8: Orphan Drugs CDMO Market, by Product

8.1 Market Overview
8.2 Active Pharmaceutical Ingredients (API)
- 8.2.1 Key Market Trends & Opportunity Analysis
- 8.2.2 Market Size and Forecast, by Region
8.3 Finished Dosage Forms (FDF)
- 8.3.1 Key Market Trends & Opportunity Analysis
- 8.3.2 Market Size and Forecast, by Region
8.4 Intermediates
- 8.4.1 Key Market Trends & Opportunity Analysis
- 8.4.2 Market Size and Forecast, by Region
8.5 Others
- 8.5.1 Key Market Trends & Opportunity Analysis
- 8.5.2 Market Size and Forecast, by Region

9: Orphan Drugs CDMO Market, by Services

9.1 Market Overview
9.2 Manufacturing
- 9.2.1 Key Market Trends & Opportunity Analysis
- 9.2.2 Market Size and Forecast, by Region
9.3 Formulation Development
- 9.3.1 Key Market Trends & Opportunity Analysis
- 9.3.2 Market Size and Forecast, by Region
9.4 Analytical and Quality Control
- 9.4.1 Key Market Trends & Opportunity Analysis
- 9.4.2 Market Size and Forecast, by Region
9.5 Regulatory Support
- 9.5.1 Key Market Trends & Opportunity Analysis
- 9.5.2 Market Size and Forecast, by Region
9.6 Clinical Trials
- 9.6.1 Key Market Trends & Opportunity Analysis
- 9.6.2 Market Size and Forecast, by Region
9.7 Supply Chain Management
- 9.7.1 Key Market Trends & Opportunity Analysis
- 9.7.2 Market Size and Forecast, by Region
9.8 Packaging
- 9.8.1 Key Market Trends & Opportunity Analysis
- 9.8.2 Market Size and Forecast, by Region
9.9 Others
- 9.9.1 Key Market Trends & Opportunity Analysis
- 9.9.2 Market Size and Forecast, by Region

10: Orphan Drugs CDMO Market, by Technology

10.1 Market Overview
10.2 Bioprocessing
- 10.2.1 Key Market Trends & Opportunity Analysis
- 10.2.2 Market Size and Forecast, by Region
10.3 Lyophilization
- 10.3.1 Key Market Trends & Opportunity Analysis
- 10.3.2 Market Size and Forecast, by Region
10.4 Spray Drying
- 10.4.1 Key Market Trends & Opportunity Analysis
- 10.4.2 Market Size and Forecast, by Region
10.5 Microencapsulation
- 10.5.1 Key Market Trends & Opportunity Analysis
- 10.5.2 Market Size and Forecast, by Region
10.6 Nanoparticle Engineering
- 10.6.1 Key Market Trends & Opportunity Analysis
- 10.6.2 Market Size and Forecast, by Region
10.7 Continuous Manufacturing
- 10.7.1 Key Market Trends & Opportunity Analysis
- 10.7.2 Market Size and Forecast, by Region
10.8 Others
- 10.8.1 Key Market Trends & Opportunity Analysis
- 10.8.2 Market Size and Forecast, by Region

11: Orphan Drugs CDMO Market, by Application

11.1 Market Overview
11.2 Oncology
- 11.2.1 Key Market Trends & Opportunity Analysis
- 11.2.2 Market Size and Forecast, by Region
11.3 Neurology
- 11.3.1 Key Market Trends & Opportunity Analysis
- 11.3.2 Market Size and Forecast, by Region
11.4 Hematology
- 11.4.1 Key Market Trends & Opportunity Analysis
- 11.4.2 Market Size and Forecast, by Region
11.5 Cardiology
- 11.5.1 Key Market Trends & Opportunity Analysis
- 11.5.2 Market Size and Forecast, by Region
11.6 Metabolic Disorders
- 11.6.1 Key Market Trends & Opportunity Analysis
- 11.6.2 Market Size and Forecast, by Region
11.7 Infectious Diseases
- 11.7.1 Key Market Trends & Opportunity Analysis
- 11.7.2 Market Size and Forecast, by Region
11.8 Genetic Disorders
- 11.8.1 Key Market Trends & Opportunity Analysis
- 11.8.2 Market Size and Forecast, by Region
11.9 Others
- 11.9.1 Key Market Trends & Opportunity Analysis
- 11.9.2 Market Size and Forecast, by Region

12: Orphan Drugs CDMO Market, by End User

12.1 Market Overview
12.2 Pharmaceutical Companies
- 12.2.1 Key Market Trends & Opportunity Analysis
- 12.2.2 Market Size and Forecast, by Region
12.3 Biotechnology Firms
- 12.3.1 Key Market Trends & Opportunity Analysis
- 12.3.2 Market Size and Forecast, by Region
12.4 Research and Academic Institutes
- 12.4.1 Key Market Trends & Opportunity Analysis
- 12.4.2 Market Size and Forecast, by Region
12.5 Contract Research Organizations (CROs)
- 12.5.1 Key Market Trends & Opportunity Analysis
- 12.5.2 Market Size and Forecast, by Region
12.6 Others
- 12.6.1 Key Market Trends & Opportunity Analysis
- 12.6.2 Market Size and Forecast, by Region

13: Orphan Drugs CDMO Market, by Stage

13.1 Market Overview
13.2 Preclinical
- 13.2.1 Key Market Trends & Opportunity Analysis
- 13.2.2 Market Size and Forecast, by Region
13.3 Phase I
- 13.3.1 Key Market Trends & Opportunity Analysis
- 13.3.2 Market Size and Forecast, by Region
13.4 Phase II
- 13.4.1 Key Market Trends & Opportunity Analysis
- 13.4.2 Market Size and Forecast, by Region
13.5 Phase III
- 13.5.1 Key Market Trends & Opportunity Analysis
- 13.5.2 Market Size and Forecast, by Region
13.6 Commercial
- 13.6.1 Key Market Trends & Opportunity Analysis
- 13.6.2 Market Size and Forecast, by Region
13.7 Others
- 13.7.1 Key Market Trends & Opportunity Analysis
- 13.7.2 Market Size and Forecast, by Region

14: Orphan Drugs CDMO Market, by Process

14.1 Market Overview
14.2 Upstream
- 14.2.1 Key Market Trends & Opportunity Analysis
- 14.2.2 Market Size and Forecast, by Region
14.3 Downstream
- 14.3.1 Key Market Trends & Opportunity Analysis
- 14.3.2 Market Size and Forecast, by Region
14.4 Formulation
- 14.4.1 Key Market Trends & Opportunity Analysis
- 14.4.2 Market Size and Forecast, by Region
14.5 Others
- 14.5.1 Key Market Trends & Opportunity Analysis
- 14.5.2 Market Size and Forecast, by Region

15: Orphan Drugs CDMO Market, by Mode

15.1 Market Overview
15.2 In-house
- 15.2.1 Key Market Trends & Opportunity Analysis
- 15.2.2 Market Size and Forecast, by Region
15.3 Outsourced
- 15.3.1 Key Market Trends & Opportunity Analysis
- 15.3.2 Market Size and Forecast, by Region
15.4 Others
- 15.4.1 Key Market Trends & Opportunity Analysis
- 15.4.2 Market Size and Forecast, by Region

16: Orphan Drugs CDMO Market, by Component

16.1 Market Overview
16.2 Equipment
- 16.2.1 Key Market Trends & Opportunity Analysis
- 16.2.2 Market Size and Forecast, by Region
16.3 Consumables
- 16.3.1 Key Market Trends & Opportunity Analysis
- 16.3.2 Market Size and Forecast, by Region
16.4 Software
- 16.4.1 Key Market Trends & Opportunity Analysis
- 16.4.2 Market Size and Forecast, by Region
16.5 Others
- 16.5.1 Key Market Trends & Opportunity Analysis
- 16.5.2 Market Size and Forecast, by Region

17: Orphan Drugs CDMO Market, by Region

17.1 Overview
17.2 North America
- 17.2.1 Key Market Trends and Opportunities
- 17.2.2 North America Market Size and Forecast, by Type
- 17.2.3 North America Market Size and Forecast, by Product
- 17.2.4 North America Market Size and Forecast, by Services
- 17.2.5 North America Market Size and Forecast, by Technology
- 17.2.6 North America Market Size and Forecast, by Application
- 17.2.7 North America Market Size and Forecast, by End User
- 17.2.8 North America Market Size and Forecast, by Stage
- 17.2.9 North America Market Size and Forecast, by Process
- 17.2.10 North America Market Size and Forecast, by Mode
- 17.2.11 North America Market Size and Forecast, by Component
- 17.2.12 North America Market Size and Forecast, by Country
- 17.2.13 United States
  - 17.2.9.1 United States Market Size and Forecast, by Type
  - 17.2.9.2 United States Market Size and Forecast, by Product
  - 17.2.9.3 United States Market Size and Forecast, by Services
  - 17.2.9.4 United States Market Size and Forecast, by Technology
  - 17.2.9.5 United States Market Size and Forecast, by Application
  - 17.2.9.6 United States Market Size and Forecast, by End User
  - 17.2.9.7 United States Market Size and Forecast, by Stage
  - 17.2.9.8 United States Market Size and Forecast, by Process
  - 17.2.9.9 United States Market Size and Forecast, by Mode
  - 17.2.9.10 United States Market Size and Forecast, by Component
  - 17.2.9.11 Local Competition Analysis
  - 17.2.9.12 Local Market Analysis
- 17.2.1 Canada
  - 17.2.10.1 Canada Market Size and Forecast, by Type
  - 17.2.10.2 Canada Market Size and Forecast, by Product
  - 17.2.10.3 Canada Market Size and Forecast, by Services
  - 17.2.10.4 Canada Market Size and Forecast, by Technology
  - 17.2.10.5 Canada Market Size and Forecast, by Application
  - 17.2.10.6 Canada Market Size and Forecast, by End User
  - 17.2.10.7 Canada Market Size and Forecast, by Stage
  - 17.2.10.8 Canada Market Size and Forecast, by Process
  - 17.2.10.9 Canada Market Size and Forecast, by Mode
  - 17.2.10.10 Canada Market Size and Forecast, by Component
  - 17.2.10.11 Local Competition Analysis
  - 17.2.10.12 Local Market Analysis
17.1 Europe
- 17.3.1 Key Market Trends and Opportunities
- 17.3.2 Europe Market Size and Forecast, by Type
- 17.3.3 Europe Market Size and Forecast, by Product
- 17.3.4 Europe Market Size and Forecast, by Services
- 17.3.5 Europe Market Size and Forecast, by Technology
- 17.3.6 Europe Market Size and Forecast, by Application
- 17.3.7 Europe Market Size and Forecast, by End User
- 17.3.8 Europe Market Size and Forecast, by Stage
- 17.3.9 Europe Market Size and Forecast, by Process
- 17.3.10 Europe Market Size and Forecast, by Mode
- 17.3.11 Europe Market Size and Forecast, by Component
- 17.3.12 Europe Market Size and Forecast, by Country
- 17.3.13 United Kingdom
  - 17.3.9.1 United Kingdom Market Size and Forecast, by Type
  - 17.3.9.2 United Kingdom Market Size and Forecast, by Product
  - 17.3.9.3 United Kingdom Market Size and Forecast, by Services
  - 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
  - 17.3.9.5 United Kingdom Market Size and Forecast, by Application
  - 17.3.9.6 United Kingdom Market Size and Forecast, by End User
  - 17.3.9.7 United Kingdom Market Size and Forecast, by Stage
  - 17.3.9.8 United Kingdom Market Size and Forecast, by Process
  - 17.3.9.9 United Kingdom Market Size and Forecast, by Mode
  - 17.3.9.10 United Kingdom Market Size and Forecast, by Component
  - 17.3.9.11 Local Competition Analysis
  - 17.3.9.12 Local Market Analysis
- 17.3.1 Germany
  - 17.3.10.1 Germany Market Size and Forecast, by Type
  - 17.3.10.2 Germany Market Size and Forecast, by Product
  - 17.3.10.3 Germany Market Size and Forecast, by Services
  - 17.3.10.4 Germany Market Size and Forecast, by Technology
  - 17.3.10.5 Germany Market Size and Forecast, by Application
  - 17.3.10.6 Germany Market Size and Forecast, by End User
  - 17.3.10.7 Germany Market Size and Forecast, by Stage
  - 17.3.10.8 Germany Market Size and Forecast, by Process
  - 17.3.10.9 Germany Market Size and Forecast, by Mode
  - 17.3.10.10 Germany Market Size and Forecast, by Component
  - 17.3.10.11 Local Competition Analysis
  - 17.3.10.12 Local Market Analysis
- 17.3.1 France
  - 17.3.11.1 France Market Size and Forecast, by Type
  - 17.3.11.2 France Market Size and Forecast, by Product
  - 17.3.11.3 France Market Size and Forecast, by Services
  - 17.3.11.4 France Market Size and Forecast, by Technology
  - 17.3.11.5 France Market Size and Forecast, by Application
  - 17.3.11.6 France Market Size and Forecast, by End User
  - 17.3.11.7 France Market Size and Forecast, by Stage
  - 17.3.11.8 France Market Size and Forecast, by Process
  - 17.3.11.9 France Market Size and Forecast, by Mode
  - 17.3.11.10 France Market Size and Forecast, by Component
  - 17.3.11.11 Local Competition Analysis
  - 17.3.11.12 Local Market Analysis
- 17.3.1 Spain
  - 17.3.12.1 Spain Market Size and Forecast, by Type
  - 17.3.12.2 Spain Market Size and Forecast, by Product
  - 17.3.12.3 Spain Market Size and Forecast, by Services
  - 17.3.12.4 Spain Market Size and Forecast, by Technology
  - 17.3.12.5 Spain Market Size and Forecast, by Application
  - 17.3.12.6 Spain Market Size and Forecast, by End User
  - 17.3.12.7 Spain Market Size and Forecast, by Stage
  - 17.3.12.8 Spain Market Size and Forecast, by Process
  - 17.3.12.9 Spain Market Size and Forecast, by Mode
  - 17.3.12.10 Spain Market Size and Forecast, by Component
  - 17.3.12.11 Local Competition Analysis
  - 17.3.12.12 Local Market Analysis
- 17.3.1 Italy
  - 17.3.13.1 Italy Market Size and Forecast, by Type
  - 17.3.13.2 Italy Market Size and Forecast, by Product
  - 17.3.13.3 Italy Market Size and Forecast, by Services
  - 17.3.13.4 Italy Market Size and Forecast, by Technology
  - 17.3.13.5 Italy Market Size and Forecast, by Application
  - 17.3.13.6 Italy Market Size and Forecast, by End User
  - 17.3.13.7 Italy Market Size and Forecast, by Stage
  - 17.3.13.8 Italy Market Size and Forecast, by Process
  - 17.3.13.9 Italy Market Size and Forecast, by Mode
  - 17.3.13.10 Italy Market Size and Forecast, by Component
  - 17.3.13.11 Local Competition Analysis
  - 17.3.13.12 Local Market Analysis
- 17.3.1 Netherlands
  - 17.3.14.1 Netherlands Market Size and Forecast, by Type
  - 17.3.14.2 Netherlands Market Size and Forecast, by Product
  - 17.3.14.3 Netherlands Market Size and Forecast, by Services
  - 17.3.14.4 Netherlands Market Size and Forecast, by Technology
  - 17.3.14.5 Netherlands Market Size and Forecast, by Application
  - 17.3.14.6 Netherlands Market Size and Forecast, by End User
  - 17.3.14.7 Netherlands Market Size and Forecast, by Stage
  - 17.3.14.8 Netherlands Market Size and Forecast, by Process
  - 17.3.14.9 Netherlands Market Size and Forecast, by Mode
  - 17.3.14.10 Netherlands Market Size and Forecast, by Component
  - 17.3.14.11 Local Competition Analysis
  - 17.3.14.12 Local Market Analysis
- 17.3.1 Sweden
  - 17.3.15.1 Sweden Market Size and Forecast, by Type
  - 17.3.15.2 Sweden Market Size and Forecast, by Product
  - 17.3.15.3 Sweden Market Size and Forecast, by Services
  - 17.3.15.4 Sweden Market Size and Forecast, by Technology
  - 17.3.15.5 Sweden Market Size and Forecast, by Application
  - 17.3.15.6 Sweden Market Size and Forecast, by End User
  - 17.3.15.7 Sweden Market Size and Forecast, by Stage
  - 17.3.15.8 Sweden Market Size and Forecast, by Process
  - 17.3.15.9 Sweden Market Size and Forecast, by Mode
  - 17.3.15.10 Sweden Market Size and Forecast, by Component
  - 17.3.15.11 Local Competition Analysis
  - 17.3.15.12 Local Market Analysis
- 17.3.1 Switzerland
  - 17.3.16.1 Switzerland Market Size and Forecast, by Type
  - 17.3.16.2 Switzerland Market Size and Forecast, by Product
  - 17.3.16.3 Switzerland Market Size and Forecast, by Services
  - 17.3.16.4 Switzerland Market Size and Forecast, by Technology
  - 17.3.16.5 Switzerland Market Size and Forecast, by Application
  - 17.3.16.6 Switzerland Market Size and Forecast, by End User
  - 17.3.16.7 Switzerland Market Size and Forecast, by Stage
  - 17.3.16.8 Switzerland Market Size and Forecast, by Process
  - 17.3.16.9 Switzerland Market Size and Forecast, by Mode
  - 17.3.16.10 Switzerland Market Size and Forecast, by Component
  - 17.3.16.11 Local Competition Analysis
  - 17.3.16.12 Local Market Analysis
- 17.3.1 Denmark
  - 17.3.17.1 Denmark Market Size and Forecast, by Type
  - 17.3.17.2 Denmark Market Size and Forecast, by Product
  - 17.3.17.3 Denmark Market Size and Forecast, by Services
  - 17.3.17.4 Denmark Market Size and Forecast, by Technology
  - 17.3.17.5 Denmark Market Size and Forecast, by Application
  - 17.3.17.6 Denmark Market Size and Forecast, by End User
  - 17.3.17.7 Denmark Market Size and Forecast, by Stage
  - 17.3.17.8 Denmark Market Size and Forecast, by Process
  - 17.3.17.9 Denmark Market Size and Forecast, by Mode
  - 17.3.17.10 Denmark Market Size and Forecast, by Component
  - 17.3.17.11 Local Competition Analysis
  - 17.3.17.12 Local Market Analysis
- 17.3.1 Finland
  - 17.3.18.1 Finland Market Size and Forecast, by Type
  - 17.3.18.2 Finland Market Size and Forecast, by Product
  - 17.3.18.3 Finland Market Size and Forecast, by Services
  - 17.3.18.4 Finland Market Size and Forecast, by Technology
  - 17.3.18.5 Finland Market Size and Forecast, by Application
  - 17.3.18.6 Finland Market Size and Forecast, by End User
  - 17.3.18.7 Finland Market Size and Forecast, by Stage
  - 17.3.18.8 Finland Market Size and Forecast, by Process
  - 17.3.18.9 Finland Market Size and Forecast, by Mode
  - 17.3.18.10 Finland Market Size and Forecast, by Component
  - 17.3.18.11 Local Competition Analysis
  - 17.3.18.12 Local Market Analysis
- 17.3.1 Russia
  - 17.3.19.1 Russia Market Size and Forecast, by Type
  - 17.3.19.2 Russia Market Size and Forecast, by Product
  - 17.3.19.3 Russia Market Size and Forecast, by Services
  - 17.3.19.4 Russia Market Size and Forecast, by Technology
  - 17.3.19.5 Russia Market Size and Forecast, by Application
  - 17.3.19.6 Russia Market Size and Forecast, by End User
  - 17.3.19.7 Russia Market Size and Forecast, by Stage
  - 17.3.19.8 Russia Market Size and Forecast, by Process
  - 17.3.19.9 Russia Market Size and Forecast, by Mode
  - 17.3.19.10 Russia Market Size and Forecast, by Component
  - 17.3.19.11 Local Competition Analysis
  - 17.3.19.12 Local Market Analysis
- 17.3.1 Rest of Europe
  - 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
  - 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
  - 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
  - 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
  - 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
  - 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
  - 17.3.20.7 Rest of Europe Market Size and Forecast, by Stage
  - 17.3.20.8 Rest of Europe Market Size and Forecast, by Process
  - 17.3.20.9 Rest of Europe Market Size and Forecast, by Mode
  - 17.3.20.10 Rest of Europe Market Size and Forecast, by Component
  - 17.3.20.11 Local Competition Analysis
  - 17.3.20.12 Local Market Analysis
17.1 Asia-Pacific
- 17.4.1 Key Market Trends and Opportunities
- 17.4.2 Asia-Pacific Market Size and Forecast, by Type
- 17.4.3 Asia-Pacific Market Size and Forecast, by Product
- 17.4.4 Asia-Pacific Market Size and Forecast, by Services
- 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
- 17.4.6 Asia-Pacific Market Size and Forecast, by Application
- 17.4.7 Asia-Pacific Market Size and Forecast, by End User
- 17.4.8 Asia-Pacific Market Size and Forecast, by Stage
- 17.4.9 Asia-Pacific Market Size and Forecast, by Process
- 17.4.10 Asia-Pacific Market Size and Forecast, by Mode
- 17.4.11 Asia-Pacific Market Size and Forecast, by Component
- 17.4.12 Asia-Pacific Market Size and Forecast, by Country
- 17.4.13 China
  - 17.4.9.1 China Market Size and Forecast, by Type
  - 17.4.9.2 China Market Size and Forecast, by Product
  - 17.4.9.3 China Market Size and Forecast, by Services
  - 17.4.9.4 China Market Size and Forecast, by Technology
  - 17.4.9.5 China Market Size and Forecast, by Application
  - 17.4.9.6 China Market Size and Forecast, by End User
  - 17.4.9.7 China Market Size and Forecast, by Stage
  - 17.4.9.8 China Market Size and Forecast, by Process
  - 17.4.9.9 China Market Size and Forecast, by Mode
  - 17.4.9.10 China Market Size and Forecast, by Component
  - 17.4.9.11 Local Competition Analysis
  - 17.4.9.12 Local Market Analysis
- 17.4.1 India
  - 17.4.10.1 India Market Size and Forecast, by Type
  - 17.4.10.2 India Market Size and Forecast, by Product
  - 17.4.10.3 India Market Size and Forecast, by Services
  - 17.4.10.4 India Market Size and Forecast, by Technology
  - 17.4.10.5 India Market Size and Forecast, by Application
  - 17.4.10.6 India Market Size and Forecast, by End User
  - 17.4.10.7 India Market Size and Forecast, by Stage
  - 17.4.10.8 India Market Size and Forecast, by Process
  - 17.4.10.9 India Market Size and Forecast, by Mode
  - 17.4.10.10 India Market Size and Forecast, by Component
  - 17.4.10.11 Local Competition Analysis
  - 17.4.10.12 Local Market Analysis
- 17.4.1 Japan
  - 17.4.11.1 Japan Market Size and Forecast, by Type
  - 17.4.11.2 Japan Market Size and Forecast, by Product
  - 17.4.11.3 Japan Market Size and Forecast, by Services
  - 17.4.11.4 Japan Market Size and Forecast, by Technology
  - 17.4.11.5 Japan Market Size and Forecast, by Application
  - 17.4.11.6 Japan Market Size and Forecast, by End User
  - 17.4.11.7 Japan Market Size and Forecast, by Stage
  - 17.4.11.8 Japan Market Size and Forecast, by Process
  - 17.4.11.9 Japan Market Size and Forecast, by Mode
  - 17.4.11.10 Japan Market Size and Forecast, by Component
  - 17.4.11.11 Local Competition Analysis
  - 17.4.11.12 Local Market Analysis
- 17.4.1 South Korea
  - 17.4.12.1 South Korea Market Size and Forecast, by Type
  - 17.4.12.2 South Korea Market Size and Forecast, by Product
  - 17.4.12.3 South Korea Market Size and Forecast, by Services
  - 17.4.12.4 South Korea Market Size and Forecast, by Technology
  - 17.4.12.5 South Korea Market Size and Forecast, by Application
  - 17.4.12.6 South Korea Market Size and Forecast, by End User
  - 17.4.12.7 South Korea Market Size and Forecast, by Stage
  - 17.4.12.8 South Korea Market Size and Forecast, by Process
  - 17.4.12.9 South Korea Market Size and Forecast, by Mode
  - 17.4.12.10 South Korea Market Size and Forecast, by Component
  - 17.4.12.11 Local Competition Analysis
  - 17.4.12.12 Local Market Analysis
- 17.4.1 Australia
  - 17.4.13.1 Australia Market Size and Forecast, by Type
  - 17.4.13.2 Australia Market Size and Forecast, by Product
  - 17.4.13.3 Australia Market Size and Forecast, by Services
  - 17.4.13.4 Australia Market Size and Forecast, by Technology
  - 17.4.13.5 Australia Market Size and Forecast, by Application
  - 17.4.13.6 Australia Market Size and Forecast, by End User
  - 17.4.13.7 Australia Market Size and Forecast, by Stage
  - 17.4.13.8 Australia Market Size and Forecast, by Process
  - 17.4.13.9 Australia Market Size and Forecast, by Mode
  - 17.4.13.10 Australia Market Size and Forecast, by Component
  - 17.4.13.11 Local Competition Analysis
  - 17.4.13.12 Local Market Analysis
- 17.4.1 Singapore
  - 17.4.14.1 Singapore Market Size and Forecast, by Type
  - 17.4.14.2 Singapore Market Size and Forecast, by Product
  - 17.4.14.3 Singapore Market Size and Forecast, by Services
  - 17.4.14.4 Singapore Market Size and Forecast, by Technology
  - 17.4.14.5 Singapore Market Size and Forecast, by Application
  - 17.4.14.6 Singapore Market Size and Forecast, by End User
  - 17.4.14.7 Singapore Market Size and Forecast, by Stage
  - 17.4.14.8 Singapore Market Size and Forecast, by Process
  - 17.4.14.9 Singapore Market Size and Forecast, by Mode
  - 17.4.14.10 Singapore Market Size and Forecast, by Component
  - 17.4.14.11 Local Competition Analysis
  - 17.4.14.12 Local Market Analysis
- 17.4.1 Indonesia
  - 17.4.15.1 Indonesia Market Size and Forecast, by Type
  - 17.4.15.2 Indonesia Market Size and Forecast, by Product
  - 17.4.15.3 Indonesia Market Size and Forecast, by Services
  - 17.4.15.4 Indonesia Market Size and Forecast, by Technology
  - 17.4.15.5 Indonesia Market Size and Forecast, by Application
  - 17.4.15.6 Indonesia Market Size and Forecast, by End User
  - 17.4.15.7 Indonesia Market Size and Forecast, by Stage
  - 17.4.15.8 Indonesia Market Size and Forecast, by Process
  - 17.4.15.9 Indonesia Market Size and Forecast, by Mode
  - 17.4.15.10 Indonesia Market Size and Forecast, by Component
  - 17.4.15.11 Local Competition Analysis
  - 17.4.15.12 Local Market Analysis
- 17.4.1 Taiwan
  - 17.4.16.1 Taiwan Market Size and Forecast, by Type
  - 17.4.16.2 Taiwan Market Size and Forecast, by Product
  - 17.4.16.3 Taiwan Market Size and Forecast, by Services
  - 17.4.16.4 Taiwan Market Size and Forecast, by Technology
  - 17.4.16.5 Taiwan Market Size and Forecast, by Application
  - 17.4.16.6 Taiwan Market Size and Forecast, by End User
  - 17.4.16.7 Taiwan Market Size and Forecast, by Stage
  - 17.4.16.8 Taiwan Market Size and Forecast, by Process
  - 17.4.16.9 Taiwan Market Size and Forecast, by Mode
  - 17.4.16.10 Taiwan Market Size and Forecast, by Component
  - 17.4.16.11 Local Competition Analysis
  - 17.4.16.12 Local Market Analysis
- 17.4.1 Malaysia
  - 17.4.17.1 Malaysia Market Size and Forecast, by Type
  - 17.4.17.2 Malaysia Market Size and Forecast, by Product
  - 17.4.17.3 Malaysia Market Size and Forecast, by Services
  - 17.4.17.4 Malaysia Market Size and Forecast, by Technology
  - 17.4.17.5 Malaysia Market Size and Forecast, by Application
  - 17.4.17.6 Malaysia Market Size and Forecast, by End User
  - 17.4.17.7 Malaysia Market Size and Forecast, by Stage
  - 17.4.17.8 Malaysia Market Size and Forecast, by Process
  - 17.4.17.9 Malaysia Market Size and Forecast, by Mode
  - 17.4.17.10 Malaysia Market Size and Forecast, by Component
  - 17.4.17.11 Local Competition Analysis
  - 17.4.17.12 Local Market Analysis
- 17.4.1 Rest of Asia-Pacific
  - 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
  - 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
  - 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
  - 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
  - 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
  - 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
  - 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
  - 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Process
  - 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Mode
  - 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Component
  - 17.4.18.11 Local Competition Analysis
  - 17.4.18.12 Local Market Analysis
17.1 Latin America
- 17.5.1 Key Market Trends and Opportunities
- 17.5.2 Latin America Market Size and Forecast, by Type
- 17.5.3 Latin America Market Size and Forecast, by Product
- 17.5.4 Latin America Market Size and Forecast, by Services
- 17.5.5 Latin America Market Size and Forecast, by Technology
- 17.5.6 Latin America Market Size and Forecast, by Application
- 17.5.7 Latin America Market Size and Forecast, by End User
- 17.5.8 Latin America Market Size and Forecast, by Stage
- 17.5.9 Latin America Market Size and Forecast, by Process
- 17.5.10 Latin America Market Size and Forecast, by Mode
- 17.5.11 Latin America Market Size and Forecast, by Component
- 17.5.12 Latin America Market Size and Forecast, by Country
- 17.5.13 Brazil
  - 17.5.9.1 Brazil Market Size and Forecast, by Type
  - 17.5.9.2 Brazil Market Size and Forecast, by Product
  - 17.5.9.3 Brazil Market Size and Forecast, by Services
  - 17.5.9.4 Brazil Market Size and Forecast, by Technology
  - 17.5.9.5 Brazil Market Size and Forecast, by Application
  - 17.5.9.6 Brazil Market Size and Forecast, by End User
  - 17.5.9.7 Brazil Market Size and Forecast, by Stage
  - 17.5.9.8 Brazil Market Size and Forecast, by Process
  - 17.5.9.9 Brazil Market Size and Forecast, by Mode
  - 17.5.9.10 Brazil Market Size and Forecast, by Component
  - 17.5.9.11 Local Competition Analysis
  - 17.5.9.12 Local Market Analysis
- 17.5.1 Mexico
  - 17.5.10.1 Mexico Market Size and Forecast, by Type
  - 17.5.10.2 Mexico Market Size and Forecast, by Product
  - 17.5.10.3 Mexico Market Size and Forecast, by Services
  - 17.5.10.4 Mexico Market Size and Forecast, by Technology
  - 17.5.10.5 Mexico Market Size and Forecast, by Application
  - 17.5.10.6 Mexico Market Size and Forecast, by End User
  - 17.5.10.7 Mexico Market Size and Forecast, by Stage
  - 17.5.10.8 Mexico Market Size and Forecast, by Process
  - 17.5.10.9 Mexico Market Size and Forecast, by Mode
  - 17.5.10.10 Mexico Market Size and Forecast, by Component
  - 17.5.10.11 Local Competition Analysis
  - 17.5.10.12 Local Market Analysis
- 17.5.1 Argentina
  - 17.5.11.1 Argentina Market Size and Forecast, by Type
  - 17.5.11.2 Argentina Market Size and Forecast, by Product
  - 17.5.11.3 Argentina Market Size and Forecast, by Services
  - 17.5.11.4 Argentina Market Size and Forecast, by Technology
  - 17.5.11.5 Argentina Market Size and Forecast, by Application
  - 17.5.11.6 Argentina Market Size and Forecast, by End User
  - 17.5.11.7 Argentina Market Size and Forecast, by Stage
  - 17.5.11.8 Argentina Market Size and Forecast, by Process
  - 17.5.11.9 Argentina Market Size and Forecast, by Mode
  - 17.5.11.10 Argentina Market Size and Forecast, by Component
  - 17.5.11.11 Local Competition Analysis
  - 17.5.11.12 Local Market Analysis
- 17.5.1 Rest of Latin America
  - 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
  - 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
  - 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
  - 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
  - 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
  - 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
  - 17.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
  - 17.5.12.8 Rest of Latin America Market Size and Forecast, by Process
  - 17.5.12.9 Rest of Latin America Market Size and Forecast, by Mode
  - 17.5.12.10 Rest of Latin America Market Size and Forecast, by Component
  - 17.5.12.11 Local Competition Analysis
  - 17.5.12.12 Local Market Analysis
17.1 Middle East and Africa
- 17.6.1 Key Market Trends and Opportunities
- 17.6.2 Middle East and Africa Market Size and Forecast, by Type
- 17.6.3 Middle East and Africa Market Size and Forecast, by Product
- 17.6.4 Middle East and Africa Market Size and Forecast, by Services
- 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
- 17.6.6 Middle East and Africa Market Size and Forecast, by Application
- 17.6.7 Middle East and Africa Market Size and Forecast, by End User
- 17.6.8 Middle East and Africa Market Size and Forecast, by Stage
- 17.6.9 Middle East and Africa Market Size and Forecast, by Process
- 17.6.10 Middle East and Africa Market Size and Forecast, by Mode
- 17.6.11 Middle East and Africa Market Size and Forecast, by Component
- 17.6.12 Middle East and Africa Market Size and Forecast, by Country
- 17.6.13 Saudi Arabia
  - 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
  - 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
  - 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
  - 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
  - 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
  - 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
  - 17.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
  - 17.6.9.8 Saudi Arabia Market Size and Forecast, by Process
  - 17.6.9.9 Saudi Arabia Market Size and Forecast, by Mode
  - 17.6.9.10 Saudi Arabia Market Size and Forecast, by Component
  - 17.6.9.11 Local Competition Analysis
  - 17.6.9.12 Local Market Analysis
- 17.6.1 UAE
  - 17.6.10.1 UAE Market Size and Forecast, by Type
  - 17.6.10.2 UAE Market Size and Forecast, by Product
  - 17.6.10.3 UAE Market Size and Forecast, by Services
  - 17.6.10.4 UAE Market Size and Forecast, by Technology
  - 17.6.10.5 UAE Market Size and Forecast, by Application
  - 17.6.10.6 UAE Market Size and Forecast, by End User
  - 17.6.10.7 UAE Market Size and Forecast, by Stage
  - 17.6.10.8 UAE Market Size and Forecast, by Process
  - 17.6.10.9 UAE Market Size and Forecast, by Mode
  - 17.6.10.10 UAE Market Size and Forecast, by Component
  - 17.6.10.11 Local Competition Analysis
  - 17.6.10.12 Local Market Analysis
- 17.6.1 South Africa
  - 17.6.11.1 South Africa Market Size and Forecast, by Type
  - 17.6.11.2 South Africa Market Size and Forecast, by Product
  - 17.6.11.3 South Africa Market Size and Forecast, by Services
  - 17.6.11.4 South Africa Market Size and Forecast, by Technology
  - 17.6.11.5 South Africa Market Size and Forecast, by Application
  - 17.6.11.6 South Africa Market Size and Forecast, by End User
  - 17.6.11.7 South Africa Market Size and Forecast, by Stage
  - 17.6.11.8 South Africa Market Size and Forecast, by Process
  - 17.6.11.9 South Africa Market Size and Forecast, by Mode
  - 17.6.11.10 South Africa Market Size and Forecast, by Component
  - 17.6.11.11 Local Competition Analysis
  - 17.6.11.12 Local Market Analysis
- 17.6.1 Rest of MEA
  - 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
  - 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
  - 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
  - 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
  - 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
  - 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
  - 17.6.12.7 Rest of MEA Market Size and Forecast, by Stage
  - 17.6.12.8 Rest of MEA Market Size and Forecast, by Process
  - 17.6.12.9 Rest of MEA Market Size and Forecast, by Mode
  - 17.6.12.10 Rest of MEA Market Size and Forecast, by Component
  - 17.6.12.11 Local Competition Analysis
  - 17.6.12.12 Local Market Analysis

18: Competitive Landscape

18.1 Overview
18.2 Market Share Analysis
18.3 Key Player Positioning
18.4 Competitive Leadership Mapping
- 18.4.1 Star Players
- 18.4.2 Innovators
- 18.4.3 Emerging Players
18.5 Vendor Benchmarking
18.6 Developmental Strategy Benchmarking
- 18.6.1 New Product Developments
- 18.6.2 Product Launches
- 18.6.3 Business Expansions
- 18.6.4 Partnerships, Joint Ventures, and Collaborations
- 18.6.5 Mergers and Acquisitions

19: Company Profiles

19.1 Lonza
- 19.1.1 Company Overview
- 19.1.2 Company Snapshot
- 19.1.3 Business Segments
- 19.1.4 Business Performance
- 19.1.5 Product Offerings
- 19.1.6 Key Developmental Strategies
- 19.1.7 SWOT Analysis
19.2 Catalent
- 19.2.1 Company Overview
- 19.2.2 Company Snapshot
- 19.2.3 Business Segments
- 19.2.4 Business Performance
- 19.2.5 Product Offerings
- 19.2.6 Key Developmental Strategies
- 19.2.7 SWOT Analysis
19.3 Samsung Biologics
- 19.3.1 Company Overview
- 19.3.2 Company Snapshot
- 19.3.3 Business Segments
- 19.3.4 Business Performance
- 19.3.5 Product Offerings
- 19.3.6 Key Developmental Strategies
- 19.3.7 SWOT Analysis
19.4 WuXi Biologics
- 19.4.1 Company Overview
- 19.4.2 Company Snapshot
- 19.4.3 Business Segments
- 19.4.4 Business Performance
- 19.4.5 Product Offerings
- 19.4.6 Key Developmental Strategies
- 19.4.7 SWOT Analysis
19.5 Boehringer Ingelheim BioXcellence
- 19.5.1 Company Overview
- 19.5.2 Company Snapshot
- 19.5.3 Business Segments
- 19.5.4 Business Performance
- 19.5.5 Product Offerings
- 19.5.6 Key Developmental Strategies
- 19.5.7 SWOT Analysis
19.6 Fujifilm Diosynth Biotechnologies
- 19.6.1 Company Overview
- 19.6.2 Company Snapshot
- 19.6.3 Business Segments
- 19.6.4 Business Performance
- 19.6.5 Product Offerings
- 19.6.6 Key Developmental Strategies
- 19.6.7 SWOT Analysis
19.7 AGC Biologics
- 19.7.1 Company Overview
- 19.7.2 Company Snapshot
- 19.7.3 Business Segments
- 19.7.4 Business Performance
- 19.7.5 Product Offerings
- 19.7.6 Key Developmental Strategies
- 19.7.7 SWOT Analysis
19.8 Thermo Fisher Scientific
- 19.8.1 Company Overview
- 19.8.2 Company Snapshot
- 19.8.3 Business Segments
- 19.8.4 Business Performance
- 19.8.5 Product Offerings
- 19.8.6 Key Developmental Strategies
- 19.8.7 SWOT Analysis
19.9 Recipharm
- 19.9.1 Company Overview
- 19.9.2 Company Snapshot
- 19.9.3 Business Segments
- 19.9.4 Business Performance
- 19.9.5 Product Offerings
- 19.9.6 Key Developmental Strategies
- 19.9.7 SWOT Analysis
19.10 Piramal Pharma Solutions
- 19.10.1 Company Overview
- 19.10.2 Company Snapshot
- 19.10.3 Business Segments
- 19.10.4 Business Performance
- 19.10.5 Product Offerings
- 19.10.6 Key Developmental Strategies
- 19.10.7 SWOT Analysis
19.11 Almac Group
- 19.11.1 Company Overview
- 19.11.2 Company Snapshot
- 19.11.3 Business Segments
- 19.11.4 Business Performance
- 19.11.5 Product Offerings
- 19.11.6 Key Developmental Strategies
- 19.11.7 SWOT Analysis
19.12 Biocon
- 19.12.1 Company Overview
- 19.12.2 Company Snapshot
- 19.12.3 Business Segments
- 19.12.4 Business Performance
- 19.12.5 Product Offerings
- 19.12.6 Key Developmental Strategies
- 19.12.7 SWOT Analysis
19.13 CordenPharma
- 19.13.1 Company Overview
- 19.13.2 Company Snapshot
- 19.13.3 Business Segments
- 19.13.4 Business Performance
- 19.13.5 Product Offerings
- 19.13.6 Key Developmental Strategies
- 19.13.7 SWOT Analysis
19.14 Patheon
- 19.14.1 Company Overview
- 19.14.2 Company Snapshot
- 19.14.3 Business Segments
- 19.14.4 Business Performance
- 19.14.5 Product Offerings
- 19.14.6 Key Developmental Strategies
- 19.14.7 SWOT Analysis
19.15 Ajinomoto Bio-Pharma Services
- 19.15.1 Company Overview
- 19.15.2 Company Snapshot
- 19.15.3 Business Segments
- 19.15.4 Business Performance
- 19.15.5 Product Offerings
- 19.15.6 Key Developmental Strategies
- 19.15.7 SWOT Analysis
19.16 Abzena
- 19.16.1 Company Overview
- 19.16.2 Company Snapshot
- 19.16.3 Business Segments
- 19.16.4 Business Performance
- 19.16.5 Product Offerings
- 19.16.6 Key Developmental Strategies
- 19.16.7 SWOT Analysis
19.17 Rentschler Biopharma
- 19.17.1 Company Overview
- 19.17.2 Company Snapshot
- 19.17.3 Business Segments
- 19.17.4 Business Performance
- 19.17.5 Product Offerings
- 19.17.6 Key Developmental Strategies
- 19.17.7 SWOT Analysis
19.18 KBI Biopharma
- 19.18.1 Company Overview
- 19.18.2 Company Snapshot
- 19.18.3 Business Segments
- 19.18.4 Business Performance
- 19.18.5 Product Offerings
- 19.18.6 Key Developmental Strategies
- 19.18.7 SWOT Analysis
19.19 Cambrex
- 19.19.1 Company Overview
- 19.19.2 Company Snapshot
- 19.19.3 Business Segments
- 19.19.4 Business Performance
- 19.19.5 Product Offerings
- 19.19.6 Key Developmental Strategies
- 19.19.7 SWOT Analysis
19.20 Siegfried
- 19.20.1 Company Overview
- 19.20.2 Company Snapshot
- 19.20.3 Business Segments
- 19.20.4 Business Performance
- 19.20.5 Product Offerings
- 19.20.6 Key Developmental Strategies
- 19.20.7 SWOT Analysis